Small-molecule elicitation of microbial secondary metabolites

Research output: Contribution to journalShort survey

55 Citations (Scopus)

Abstract

Microbial natural products continue to be an unparalleled resource for pharmaceutical lead discovery, but the rediscovery rate is high. Bacterial and fungal sequencing studies indicate that the biosynthetic potential of many strains is much greater than that observed by fermentation. Prodding the expression of such silent (cryptic) pathways will allow us to maximize the chemical diversity available from microorganisms. Cryptic metabolic pathways can be accessed in the laboratory using molecular or cultivation-based approaches. A targeted approach related to cultivation-based methods is the application of small-molecule elicitors to specifically affect transcription of secondary metabolite gene clusters. With the isolation of the novel secondary metabolites lunalides A and B, oxylipins, cladochromes F and G, nygerone A, chaetoglobosin-542, -540 and -510, sphaerolone, dihydrosphaerolone, mutolide and pestalone, and the enhanced production of known secondary metabolites like penicillin and bacitracin, chemical elicitation is proving to be an effective way to augment natural product libraries.

Original languageEnglish (US)
Pages (from-to)471-478
Number of pages8
JournalMicrobial Biotechnology
Volume4
Issue number4
DOIs
StatePublished - Jul 1 2011

Fingerprint

Metabolites
Biological Products
Oxylipins
Bacitracin
Molecules
Multigene Family
Metabolic Networks and Pathways
Penicillins
Fermentation
Transcription
Microorganisms
Drug products
Genes
Pharmaceutical Preparations
sphaerolone
dihydrosphaerolone
Lead
pestalone
chaetoglobosins
nygerone A

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Biotechnology
  • Biochemistry
  • Bioengineering
  • Medicine(all)

Cite this

Small-molecule elicitation of microbial secondary metabolites. / Pettit, Robin.

In: Microbial Biotechnology, Vol. 4, No. 4, 01.07.2011, p. 471-478.

Research output: Contribution to journalShort survey

@article{472b291ee5f448bdbf651ac736de7c6b,
title = "Small-molecule elicitation of microbial secondary metabolites",
abstract = "Microbial natural products continue to be an unparalleled resource for pharmaceutical lead discovery, but the rediscovery rate is high. Bacterial and fungal sequencing studies indicate that the biosynthetic potential of many strains is much greater than that observed by fermentation. Prodding the expression of such silent (cryptic) pathways will allow us to maximize the chemical diversity available from microorganisms. Cryptic metabolic pathways can be accessed in the laboratory using molecular or cultivation-based approaches. A targeted approach related to cultivation-based methods is the application of small-molecule elicitors to specifically affect transcription of secondary metabolite gene clusters. With the isolation of the novel secondary metabolites lunalides A and B, oxylipins, cladochromes F and G, nygerone A, chaetoglobosin-542, -540 and -510, sphaerolone, dihydrosphaerolone, mutolide and pestalone, and the enhanced production of known secondary metabolites like penicillin and bacitracin, chemical elicitation is proving to be an effective way to augment natural product libraries.",
author = "Robin Pettit",
year = "2011",
month = "7",
day = "1",
doi = "10.1111/j.1751-7915.2010.00196.x",
language = "English (US)",
volume = "4",
pages = "471--478",
journal = "Microbial Biotechnology",
issn = "1751-7907",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Small-molecule elicitation of microbial secondary metabolites

AU - Pettit, Robin

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Microbial natural products continue to be an unparalleled resource for pharmaceutical lead discovery, but the rediscovery rate is high. Bacterial and fungal sequencing studies indicate that the biosynthetic potential of many strains is much greater than that observed by fermentation. Prodding the expression of such silent (cryptic) pathways will allow us to maximize the chemical diversity available from microorganisms. Cryptic metabolic pathways can be accessed in the laboratory using molecular or cultivation-based approaches. A targeted approach related to cultivation-based methods is the application of small-molecule elicitors to specifically affect transcription of secondary metabolite gene clusters. With the isolation of the novel secondary metabolites lunalides A and B, oxylipins, cladochromes F and G, nygerone A, chaetoglobosin-542, -540 and -510, sphaerolone, dihydrosphaerolone, mutolide and pestalone, and the enhanced production of known secondary metabolites like penicillin and bacitracin, chemical elicitation is proving to be an effective way to augment natural product libraries.

AB - Microbial natural products continue to be an unparalleled resource for pharmaceutical lead discovery, but the rediscovery rate is high. Bacterial and fungal sequencing studies indicate that the biosynthetic potential of many strains is much greater than that observed by fermentation. Prodding the expression of such silent (cryptic) pathways will allow us to maximize the chemical diversity available from microorganisms. Cryptic metabolic pathways can be accessed in the laboratory using molecular or cultivation-based approaches. A targeted approach related to cultivation-based methods is the application of small-molecule elicitors to specifically affect transcription of secondary metabolite gene clusters. With the isolation of the novel secondary metabolites lunalides A and B, oxylipins, cladochromes F and G, nygerone A, chaetoglobosin-542, -540 and -510, sphaerolone, dihydrosphaerolone, mutolide and pestalone, and the enhanced production of known secondary metabolites like penicillin and bacitracin, chemical elicitation is proving to be an effective way to augment natural product libraries.

UR - http://www.scopus.com/inward/record.url?scp=79960105974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960105974&partnerID=8YFLogxK

U2 - 10.1111/j.1751-7915.2010.00196.x

DO - 10.1111/j.1751-7915.2010.00196.x

M3 - Short survey

C2 - 21375710

AN - SCOPUS:79960105974

VL - 4

SP - 471

EP - 478

JO - Microbial Biotechnology

JF - Microbial Biotechnology

SN - 1751-7907

IS - 4

ER -